Global Implanted Venous Access Device Market Insights, Forecast to 2025

This report studies the global market size of Implanted Venous Access Device in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Implanted Venous Access Device in these regions.
This research report categorizes the global Implanted Venous Access Device market by top players/brands, region, type and end user. This report also studies the global Implanted Venous Access Device market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

Implanted Venous Access Devices are small, flexible tubes placed in large veins for people who require frequent access to the bloodstream.
The major drivers for the market include the growing prevalence of lifestyle diseases, an increase in the number of chemotherapy procedures and the increasing use of vascular access devices in pediatric patients.The global market for central vascular access devices in led by North America,In Europe and Latin America, the Implanted Venous Access Device is expected to witness unprecedented growth over the coming years. Other regions including Asia Pacific (APAC) and the Middle East and Africa (MEA) are also projected to register a positive rate in the future. All of these regions cumulatively add to the growth of the global market.
The global Implanted Venous Access Device market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Implanted Venous Access Device market based on company, product type, end user and key regions.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Becton, Dickinson and Company
C. R. Bard, Inc.
Smiths Medical, Inc.
Teleflex Incorporated
B. Braun Melsungen AG
Nipro Corporation
Edwards Lifesciences
Terumo Corporation
Vygon (UK) Ltd
Ameco Medical Industries
AngioDynamics, Inc.
Romsons
PRODIMED

Market size by Product
PICC
Centrally Inserted Catheters (non-tunnelled and tunnelled)
Implanted Ports
Others
Market size by End User
Hospital
Non-Hospital

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Implanted Venous Access Device market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To understand the structure of Implanted Venous Access Device market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Implanted Venous Access Device companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Implanted Venous Access Device submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Implanted Venous Access Device are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Implanted Venous Access Device market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions